Skip to main content

View most popular

Social Links

  • Search
  • Twitter
  • LinkedIn

Header top menu

  • About Us
  • Contact

Members

  • Create new Account
  • Subscribe
  • Log in
Home

Main navigation

  • Sections
    • BioPharma
    • Medicine
    • Patients
    • Payers
    • Politics
    • Research
  • Topics
    • access+affordability
    • global+growth
    • evaluations+economics
    • technology+therapeutics
    • policy+practice
  • Regions
    • Africa
    • Asia - Central
    • Asia - East
    • Asia - South
    • Asia-West / Mid-East / North-Africa
    • Europe
    • Global
    • North America
    • South America
    • South Pacific
  • Videos
  • Reports
  • Resources
    • Archives
    • Events
    • Links
    • Newsletter archive

Feasibility and Attractiveness of Indication Value-Based Pricing in Key EU Countries

@tandfonline May 10, 2016

Bookmark this

How the reimbursement and pricing environment allows for IBP in seven European countries, evaluating both incentives and hurdles.

Visit This Website Journal of Market Access & Health Policy
Like
5 views
Like

Download this Report

Comments

No comments yet. Create an account and log in to post a comment.

Subscribe by email

Follow Us:

  • Search
  • Twitter
  • LinkedIn
Home

News & Intelligence on BioPharmaceutical Pricing & Access

Footer

  • About Us
  • Contact

Created by Heat Informatics © 2016-2023
Web development by Woolwich Web Works

Join Us

It looks like you're enjoying the content on Heat Informatics. 

  • Join the Community
  • Get the Newsletter